We need your help to achieve the goal of growing our online, geographically searchable database of resources and support for cancer patients, their families and caregivers. Whether you're in the initial phase of shock, in the battle, or handling the aftermath of cancer, our resources take out the stress of searching multiple places and thousands of online listings.
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
Patients who received Mohs surgery to treat the most serious form of skin cancer, melanoma, reported a 95 percent long-term satisfaction rate with their results, according to a new study by UT Southwestern Medical Center dermatologists.
Due to the rarity of advanced cutaneous squamous cell carcinoma (cSCC), staying current with the latest information on diagnosing, treating, and supporting patients with this diagnosis can be challenging for clinicians who do not often encounter advanced cSCC in practice.
A drug used to treat chronic myeloid leukemia appears to be more effective at stopping a type of medulloblastoma in mouse models than existing treatments for the deadly pediatric brain tumor, reports a multi-institutional team led by researchers at Skaggs School of Pharmacy and Pharmaceutical Sciences at University of California San Diego.
The outer layer of the skin completely replaces itself every two to four weeks, but when this process is blocked, cancer can grow.
Diane and Phil Hannah started their lifelong journey together as neighbors who would talk to each other from their bedroom windows. They were high school sweethearts before they married in 1952.
Under the leadership of Vishal A. Patel, MD, FAAD, FACMS, director of the Cutaneous Oncology Program at the George Washington University Cancer Center, the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
Skin cancer is the most common cancer in the U.S., affecting one in five Americans in their lifetime. Limiting exposure to ultraviolet radiation is the number one way individuals can reduce their risk of skin cancer, though new data suggests that UV exposure is on the rise, particularly among Caucasian girls and young women.
It is a well known fact that the sun’s ultraviolet rays can damage the skin. Now, a new study sheds light on what happens after DNA damage occurs, and how the body initiates repair.
Sun safety practices for attendees at skin cancer screening events differ from the general public, according to findings published by researchers from the George Washington University Cancer Center.